Thomas B. Neff
27Patents
9h-index
29Co-inventors
75Inventor score
Filing activity: May 27, 1998 → Dec 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6992172B1 | Recombinant gelatins | Human Necessities | 93 | Expired |
| US7618940B2 | Fat regulation | Human Necessities | 28 | Expired |
| US7405274B2 | Connective tissue growth factor antibodies | Chemistry; Metallurgy | 23 | Expired |
| US7115390B1 | Connective tissue growth factor fragments and methods and uses thereof | Human Necessities | 15 | Expired |
| US8318703B2 | Methods for improving kidney function | Physics | 15 | Active |
| US5925736A | Collagen-based methods and formulations for the treatment of arthritis | Emerging Cross-Sectional Technologies | 15 | Expired |
| US8466172B2 | Stabilization of hypoxia inducible factor (HIF) alpha | Physics | 12 | Active |
| US8629131B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 10 | Active |
| US8609646B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 9 | Active |
| US8604012B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 9 | Active |
| US9920011B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 9 | Active |
| US8614204B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 6 | Active |
| US7871617B2 | Antibodies that bind to a portion of the VWC domain of connective tissue growth factor | Chemistry; Metallurgy | 5 | Active |
| US8604013B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 5 | Active |
| US10626090B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 5 | Active |
| US7393928B2 | Recombinant gelatins | Emerging Cross-Sectional Technologies | 4 | Expired |
| US10927081B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 2 | Active |
| US10882827B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 2 | Active |
| US10894774B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 2 | Active |
| US9102721B2 | Therapeutic method | Human Necessities | 1 | Active |
| US8865173B2 | Treatments for pancreatic cancer metastases | Physics | 1 | Active |
| US8314059B2 | Diabetic nephropathy therapies | Human Necessities | 0 | Active |
| US11680048B2 | Enhanced erythropoiesis and iron metabolism | Chemistry; Metallurgy | 0 | Active |
| US8728468B2 | Treatments for cancer | Physics | 0 | Active |
| US9034643B2 | Connective tissue growth factor antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.